{
    "title": "Biogen to study Spinraza in combination with $2 mln Novartis drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8544843/Biogen-assess-Spinraza-benefits-treatment-Novartis-Zolgensma.html",
    "date": "2020-07-21",
    "keywords": [
        "treatment",
        "drug",
        "novartis",
        "biogen",
        "gene",
        "therapy",
        "zolgensma",
        "year",
        "manojna",
        "maddipatla",
        "john",
        "miller",
        "atrophy",
        "drugmaker",
        "spinraza",
        "sma",
        "july",
        "top",
        "millionperpatient",
        "list",
        "price",
        "cause",
        "death",
        "entry",
        "oneoff",
        "quarter",
        "study",
        "call",
        "announcement",
        "executive",
        "vas",
        "narasimhan",
        "progress",
        "medicine",
        "branaplam",
        "age",
        "patient",
        "market",
        "roche",
        "partner",
        "approval",
        "food",
        "administration",
        "month",
        "potential",
        "infusion",
        "reporting",
        "bengaluru",
        "editing",
        "syamnath",
        "david",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}